Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$5.3 million.

  • Medifast's Cash from Operations fell 669.09% to -$5.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $6.9 million, marking a year-over-year decrease of 7196.03%. This contributed to the annual value of $6.9 million for FY2025, which is 7196.03% down from last year.
  • According to the latest figures from Q4 2025, Medifast's Cash from Operations is -$5.3 million, which was down 669.09% from $12.1 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Cash from Operations ranged from a high of $65.3 million in Q1 2021 and a low of -$7.5 million during Q4 2021
  • Moreover, its 5-year median value for Cash from Operations was $14.4 million (2021), whereas its average is $23.4 million.
  • In the last 5 years, Medifast's Cash from Operations soared by 79364.53% in 2022 and then plummeted by 14701.58% in 2024.
  • Over the past 5 years, Medifast's Cash from Operations (Quarter) stood at -$7.5 million in 2021, then skyrocketed by 793.65% to $51.7 million in 2022, then tumbled by 79.66% to $10.5 million in 2023, then plummeted by 147.02% to -$4.9 million in 2024, then decreased by 6.69% to -$5.3 million in 2025.
  • Its Cash from Operations was -$5.3 million in Q4 2025, compared to $12.1 million in Q3 2025 and -$3.4 million in Q2 2025.